CD79A and infection: Given that early mucosal immunoglobulin A (IgA) and binding-blocking IgA and IgG anti-norovirus antibodies are the most important correlates of protection,24,25 Ig preparations are expected to contain blocking/neutralizing antibodies against circulating noroviruses, and consequently resolve the infection in patients.